NDC 70518-3155

Otezla

Apremilast

Otezla is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Apremilast.

• Product ID: 70518-3155_c72a8ce4-ed43-7959-e053-2995a90a2c20
• NDC: 70518-3155
• Product Type: Human Prescription Drug
• Proprietary Name: Otezla
• Generic Name: Apremilast
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2021-07-14
• Marketing Category: NDA /
• Application Number: NDA205437
• Labeler Name: REMEDYREPACK INC.
• Substance Name: APREMILAST
• Active Ingredient Strength: 30 mg/1
• Pharm Classes: Phosphodiesterase 4 Inhibitor [EPC],Phosphodiesterase 4 Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 70518-3155-0

30 POUCH in 1 BOX (70518-3155-0) > 1 TABLET, FILM COATED in 1 POUCH (70518-3155-1)

• Marketing Start Date: 2021-07-14
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Otezla" or generic name "Apremilast"

NDC	Brand Name	Generic Name
55513-137	Otezla	apremilast
55513-369	Otezla	apremilast
55513-485	Otezla	apremilast
59572-630	OTEZLA	apremilast
59572-631	OTEZLA	apremilast
59572-632	OTEZLA	apremilast
70518-3155	Otezla	apremilast
60219-1410	APREMILAST	APREMILAST
60219-1744	APREMILAST	APREMILAST